Fingerprint
Dive into the research topics where Erik Wambre is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop
Rabin, R. L., Altman, M. C., Arshad, S. H., Beger, R. D., Frischmeyer-Guerrerio, P. A., Goleva, E., Hamilton, R. G., Khurana Hershey, G. K., Shamji, M. H., Sampson, H. A., Santos, A. F., Shreffler, W. G., Togias, A., Vieths, S., Wambre, E., Wenzel, S. E., Hise, K., Lee, J., Tripathi, A. & Slater, J. E., Jun 2025, In: Journal of Allergy and Clinical Immunology. 155, 6, p. 1753-1766 14 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy
Chinthrajah, R. S., Sindher, S. B., Nadeau, K. C., Leflein, J. G., Spergel, J. M., Petroni, D. H., Jones, S. M., Casale, T. B., Wang, J., Carr, W. W., Shreffler, W. G., Wood, R. A., Wambre, E., Liu, J., Akinlade, B., Atanasio, A., Orengo, J. M., Hamilton, J. D., Kamal, M. A. & Hooper, A. T. & 6 others, , Mar 2025, In: Allergy: European Journal of Allergy and Clinical Immunology. 80, 3, p. 827-842 16 p.Research output: Contribution to journal › Article › peer-review
Open Access22 Scopus citations -
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study
Sindher, S. B., Nadeau, K. C., Chinthrajah, R. S., Leflein, J. G., Bégin, P., Ohayon, J. A., Ponda, P., Wambre, E., Liu, J., Khokhar, F. A., Akinlade, B., Maloney, J., Orengo, J. M., Hamilton, J. D., Kamal, M. A., Hooper, A. T., Patel, N., Patel, K., Laws, E. & Mannent, L. P. & 1 others, , Jan 2025, In: Allergy: European Journal of Allergy and Clinical Immunology. 80, 1, p. 227-237 11 p.Research output: Contribution to journal › Article › peer-review
Open Access26 Scopus citations -
Phase 1 study of safety, tolerability, and efficacy of intradermal DNA vaccine ASP2390 in adults allergic to house dust mites
Kayser, T., Smulders, R., Kusawake, T., Wambre, E., Chichili, G. R., Blauwet, M. B., Spence, A., Patton, M., Tabash, R., DeBerg, H. A., Khosa, S., Badorrek, P., Hohlfeld, J. M. & Ferslew, B. C., May 2025, In: Journal of Allergy and Clinical Immunology: Global. 4, 2, 100404.Research output: Contribution to journal › Article › peer-review
Open Access -
Mechanisms and Predictive Biomarkers of Allergen Immunotherapy in the Clinic
Layhadi, J. A., Lalioti, A., Palmer, E., van Zelm, M. C., Wambre, E. & Shamji, M. H., Jan 2024, In: Journal of Allergy and Clinical Immunology: In Practice. 12, 1, p. 59-66 8 p.Research output: Contribution to journal › Article › peer-review
Open Access30 Scopus citations
Press/Media
-
Stories Behind the Science: A New Way Forward With Food Allergies
Hirschhorn, K., Sampson, H., Curotto de Lafaille, M., Bunyavanich, S., Sicherer, S. & Wambre, E.
12/08/25
1 item of Media coverage
Press/Media